University of Crete (UOC)
Διερεύνηση του ρόλου των μαστοκυττάρων και CXC ELR motif (ELR+) χυμοκινών στην αγγειογένεση του πολλαπλού μυελώματος
Abstract
dc:descriptionBackground: Multiple myeloma is a malignant plasma cell diseaes, being located in bonemarrow. Malignant cells interact with bone marrow microenvironment, modifying it.Angiogenesis represents the formation of new blood vessels from pre-existing ones, isdependent on those interactions, and finally is implicated in the development of tumorby multiple manners. Angiogenesis process has been studied in both benign andmalignant diseases included multiple myeloma, achieving the development of antiangiogenictherapies, even in myeloma, with satisfying results. Despite the progress in theunderstanding of myeloma pathophysiology, the disease remains incurable. Therefore,the investigation of implicated mechanisms in the biology of myeloma evolution isnessecary.Aim of the study: The aim of the study was to investigate the role of ELR CXC+chemokines and mast cells in angiogenic activity of multiple myeloma. Circulating levelsof those chemokines in the peripheral blood, as well mast cells’ location in bone marrowwere studied. Furthermore, their relationship with bone marrow angiogenic process wasalso studied.Patients and methods: Sixty-three myeloma patients were studied during diagnosis.Moreover, 30 of them achieving remission after therapy as well 30 healthy controls werealso studied. This was a study in 2 phases. Initially, ELR+ CXC chemokines (GRO-α,ENA-78 and ΙL-8) were measured in peripheral blood, along with the estimation of bonemarrow angiogenic activity, both directly, estimating bone marrow microvascular density(MVD) and indirectly, measuring circulating levels of known angiogenic cytokines, suchas HGF, VEGF, TNF-α, angiogenin and PDGF-AB. In the next phase, bone marrowmast cell density (MCD) was estimated, along with the estimation of bone marrowangiogenic activity, both directly, estimating bone marrow microvascular density (MVD) and indirectly, measuring circulating levels of known angiogenic cytokines, such asVEGF, bFGF, TNF-α, as well ELR+ CXC chemokines.Results: All measured variables were significantly increased in multiple myeloma patientscompared to healthy population. Furthermore, they were all increasing in parallel withdisease activity, with the exception of ENA-78. Similarly, all variables decreased aftereffective treatmen, with the exceptions of ENA-78 and GRO-α, where no difference wasfound. Significant positive correlations were found between GRO-α with HGF, VEGF,TNF-α, MVD and MCD. Significant positive correlations were also noted betweenΕΝΑ-78 with VEGF, TNF-α and MCD but not with MVD. IL-8 also correlated with TNF-α, PDGF-AB, angiogenin and MCD, but also not with MVD. Finally, MCDcorrelated with MVD and all angiogenic cytokines as well.Conclusions: Circulating levels of ELR+ CXC chemokines (IL-8, GRO-α and ΕΝΑ-78), as well bone marrow MCD are elevated in multiple myeloma patients, are dependenton disease stage and decrease after effective therapy. Their correlations with theangiogenic process suggest their participation in multiple myeloma angoiogenesis.
Degree
thesis:*- Grantor dc:publisher
- University of Crete (UOC)
- Year dc:date
- 2013
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Pappa, Constantina
- Παππά, Κωνσταντίνα
Subjects
dc:subject × 14Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/37994